MD03 Scalp Protocol offers comprehensive, quantitative scalp microbiome analysis using an at-home swab kit. It provides absolute data for effective product development and marketing validation, detecting various microbes and linking changes to clinical outcomes.
The MD03 Scalp Microbiome Protocol is an innovative consumer solution designed for comprehensive scalp microbiome analysis. Utilizing an at-home swab kit, it provides absolute quantitative data, allowing for detailed sample comparison and time series analysis. This protocol is particularly beneficial for product developers and marketers looking to substantiate claims with scientifically robust data. By leveraging whole-genome shotgun metagenomic sequencing, the protocol identifies a wide range of microbes such as viruses, bacteria, fungi, and mites at species and strain levels. This capability enables the revelation of product effects on the microbiome and links these changes to physiological, lifestyle, and health outcomes.
Key features:
The MD03 Scalp Microbiome Protocol has been validated through extensive consumer testing, achieving a Technology Readiness Level of 6. Future validation is planned via trials on anti-dandruff shampoos, further establishing its efficacy and application in product development.
A young biotech startup specializing in microbiome-based skincare. Founded by a team of scientists and entrepreneurs, it aims to revolutionize dermatology by combining genomics and phage therapeutics for consumer use.